JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (4): 60-63.doi: 10.6040/j.issn.1671-7554.0.2015.1200

Previous Articles     Next Articles

Effect of erythropoietin on hypoxic ischemic encephalopathy in neonates

ZHU Jing1, GUO Aili2, ZHANG Nan2, QIN Mingming2, LIU Lijuan3, ZHU Weiwei2   

  1. 1. Taishan Medical University, Taian 271000, Shandong, China;
    2. Department of Pediatrics, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China;
    3. School of Medicine, Shandong University School of Medicine, Jinan 250012, Shandong, China
  • Received:2015-12-01 Online:2016-04-10 Published:2016-04-10

PDF (PC)

314

Abstract: Objective To observe the curative effect of erythropoietin(EPO)in the treatment of neonatal hypoxi-ischemic Encephalopathy(HIE). Methods A total of 81 cases of neonatal HIE were randomly divided into EPO treatment group(n=42)and control group(n=39), and healthy full-term neonates born during the same period were randomly selected as the normal control group. The control group and treatment group were given conventional treatment. Besides that, the EPO treatment group was intravenously injected with EPO 200 IU/kg a day, 3 times a week for 2 weeks. All patients undertook neonatal behavior neurological determination(NBNA)on day 7, 14 and 28 after birth, and received infant intelligence development assessment(CDCC)3 and 6 months after birth. All babies were followed up 6 and 12 months after birth. Results The NBNA score 7 days after birth had no statistical difference between the treatment group and control group, which was lower than that of normal group(P<0.01). The treatment group had higher NBNA scores 14 and 28 days than the control group(P<0.05), which were still lower than those of the normal group(P<0.01). The treatment group had higher CDCC score 3 months after birth than the control group(P<0.05), which was lower than that of the normal group(P<0.01). Six months after birth, the CDCC score of the treatment group was significantly higher than that of the control group(P<0.05), and there was no difference between the normal group and normal group in MDI, but the PDI of the treatment group was still lower than that of the normal group(P<0.05). 山 东 大 学 学 报 (医 学 版)54卷4期 -朱静,等.促红细胞生成素治疗新生儿缺氧缺血性脑病的疗效观察 \=- Conclusion The efficacy of EP0 works more effectively than ganglioside therapy in treatment of neonatal HIE.

Key words: Hypoxic-ischemic encephalopathy, Neonate, Erythropoietin

CLC Number: 

  • R725
[1] 蔡清, 薛辛东, 富建华. 新生儿缺氧缺血性脑病研究现状及进展[J]. 中国实用儿科杂志, 2009, 12: 968-971.
[2] Eunson P. The long-term health, social, and financial burden of hypoxic-ischaemic encephalopathy[J]. Dev Med Child Neurol, 2015, 57(3): 48-50.
[3] Pankratova S, Kiryushko D, Sonn K, et al. Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor[J]. Brain, 2010, 133(8): 2281-2294.
[4] Zhu L, Bai X, Wang S, et al. Recombinant human erythropoietin augments angiogenic responses in a neonatal rat model of cerebral unilateral hypoxia-ischemia[J]. Neonatology, 2014, 106(2): 143-148.
[5] 中华医学会儿科学分会新生儿学组. 新生儿缺氧缺血性脑病诊断标准[J]. 中国当代儿科杂志, 2005, 7(2): 97-98.
[6] 金汉珍, 黄德珉, 官希吉. 实用新生儿学[M]. 3版. 北京:人民卫生出版社, 2003:766-771.
[7] 周丛乐, 宋琳琳. 新生儿缺氧缺血性脑病[M] //金汉珍, 黄德珉, 官希吉. 实用新生儿学. 3 版.北京: 人民卫生出版社, 2004:770.
[8] 邵肖梅. 早产儿脑损伤和脑性瘫痪[J]. 实用儿科临床杂志, 2003, 3: 163-165.
[9] 范存仁. 婴幼儿智能发育测验手册[M]. 北京: 团结出版社, 1998: 24.
[10] Jackevicius CA, Fan CS, Warner A. Clinical outcomes of erythropoietin use in heart failure patients with anemia of chronic kidney disease[J]. J Card Fail, 2014, 20(5): 327-333.
[11] Alexander ML, Hill CA, Rosenkrantz TS, et al. Evaluation of the therapeutic benefit of delayed administration of erythropoietin following early hypoxic-ischemic injury in rodents[J]. Dev Neurosci, 2012, 34(6): 515-524.
[12] Nguyen AQ, Cherry BH, Scott GF, et al. Erythropoietin:powerful protection of ischemic and post-ischemic brain[J]. ExpBiol Med(Maywood), 2014, 239(11): 1461-1475.
[13] Fang AY, Gonzalez FF, Sheldon RA, et al. Effects of combination therapy using hypothermia and erythropoietin in a rat model of neonatal hypoxia-ischemia[J]. Pediatr Res, 2013, 73(1): 12-17.
[14] Traudt CM, McPherson RJ, Bauer LA, et al. Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia[J]. Dev Neurosci, 2013, 35(6): 491-503.
[15] Fan X, van Bel F, van der Kooij MA, et al. Hypothermia and erythropoietin for neuroprotection after neonatal brain damage[J]. Pediatr Res, 2013, 73(1): 18-23.
[16] Stohlawetz PJ, Dzirlo L, Hergovich N, et al. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans[J]. Blood, 2000, 95(9): 2983-2989.
[17] Zhu C, Kang W, Xu F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy[J]. Pediatrics, 2009, 124(2): 218-226.
[18] Jantzie LL, Miller RH, Robinson S. Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury[J]. Pediatr Res, 2013, 74(6): 658-667.
[19] Li J, Guo W, Xiong M, et al. Effect of SDF-1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury[J]. IntJ Mol Med, 2015, 14. doi: 10.3892/ijmm.2015.2344.[Epub ahead of print] PubMed PMID: 26398409.
[20] Wang X, Chen Y, Kuang D, et al. The cardioprotective effects of erythropoietin in myocardial ischemic injury via upregulation of SDF-1 by JAK2/STAT3[J]. Int J Cardiol, 2012, 156(3): 320-322.
[1] ZANG Lijiao, QIU Jie, ZHUANG Genmiao, AN Li. Correlation among serum S100B protein, NSE and neonatal hypoglycemic brain damage [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(4): 51-54.
[2] ZHUANG Genmiao, TANG Ling, ZANG Lijiao, AN Li. Correlation between serum prealbumin and neonatal behavioral neurological assessment of hypoxic-ischemic encephalopathy in neonates [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(12): 37-40.
[3] GAO Nannan, CHEN Dong, YU Yonghui, ZHANG Lili. Significance of different biomarkers on assessing the surgical treatment of necrotizing enterocolitis in the newborn [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 73-76.
[4] ZHOU Dong, CHANG Hong, SUN Ruopeng. Neuroprotection of sodium pyruvate on repetitive and profound neonatal hypoglycemic brain injury [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(4): 37-42.
[5] BAO Ju, QU Yuan, WANG Dongxin. Influence of biological rhythm on delivery mode of pregnant women receiving analgesia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(7): 75-77.
[6] WANG Fu1, LIU Shan-wen1, LI Bin2, GENG Hai-hua3, SUN Shuai1, LI Rui1, XIAO Jie1， JI Xiao-ping1. Protective effects of rhEPO on oxidative stress damage in cardiomyocytes and on heart after myocardial infarction [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(7): 1-5.
[7] WANG Lei, GUAN Guang-ju. Effect of rHuEPO on the proliferation and TGF-β mRNA expressions of
rat mesangial cells induced by high glucose [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(5): 65-69.
[8] DIAO Zeng-yan1， WANG Cui-lan1， TAN Dong2， LIU Jun-li3， LI Xue-hui4， LOU Jian-wei2， YAN Chuan-zhu2 . Preparation of carbamylated erythropoietin and its protective effect on SH-SY5Y cells injured by hydrogen peroxide [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(9): 6-.
[9] CHENG Kai1,2, ZHANG Lin-na1, SUN Ming2, HOU Qian2, ZHANG Min2, YANG Hai-xia2. Screening for retinopathy of prematurity：an analysis of 773 premature babies [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(9): 149-152.
[10] WANG Na, SUN Zheng-yun, WANG He-li, LIN Xia, LIU Yan-e. Changes of blood glucose, insulin and cortisol levels in infants of gestational diabetic mothers and healthy macrosomia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(6): 8-.
[11] WANG He-li1, SUN Xue-mei2, SUN Zheng-yun1, WANG Na1, LIN Xia1. Changes of CD3+, CD4+ and CD8+ T cells and natural killer cells in neonates born to gestational diabetes mellitus mothers and  their relationship with blood glucose [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 4-.
[12] NING Bin1, ZHANG Aijun2, JIA Tanghong1, SONG Hongliang1, GUO Shuya1, GONG Weiming1. Inhibitory effect of recombinant human erythropoietin on motor neuron apoptosis  during cervical chronic spinal cord compression in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(4): 59-63.
[13] WANG Zun-song1，Zhang Rui-feng2，XU Dong-mei1，CUI Mei-yu1. Effect of ultrapure dialysate on erythropoietin  resistance in hemodialysis patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(12): 90-93.
[14] ZHOU Dong1, QIAN Jing2, CHANG Hong3, LI Fu-hai1, SUN Ruo-peng1 . Neurodegeneration in different brain regions of neonatal  rats damaged by hypoglycemia  [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(11): 84-.
[15] HUANG Tao,LIN Xiao-ying,LI Fang-lin,ZHONG Ning,LIU Yun-fang,MENG Xiao-hui,ZHENG Yu-lan,SONG Wen-yan. Effects of erythropoietin on heme oxygenase-1 expression in rats with globle ischemia-reperfusion injury [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(3): 225-228.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd